FDA Inspection
New York Presbyterian Hospital ServicesNew York Presbyterian Hospital Services – FDA Inspection, Sep 10, 2025
Record Details
This FDA Inspection record concerns New York Presbyterian Hospital Services, with an inspection on September 10, 2025, issued by the New York District Office, covering biologics.
- Inspection Date
- September 10, 2025
- Product Type
- Biologics
View Company Profile
ID · 380016a7-cf2e-495e-a359-348108916766
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1281114
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 606.160(b)Required records
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Presbyterian Hospital Services
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 28, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Presbyterian Hospital Services
- FDA Inspection 1215867 - 2023-08-21
- FDA Inspection 1080428 - 2019-02-07
- FDA Inspection 990270 - 2016-10-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.